ALLIANCEBERNSTEIN L.P.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1109448 NASHVILLE, TN

Position in RDY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,205,162

+$34,784,510 QoQ

Shares Held

2,541,889

+8384.0% QoQ

Ownership

0.305%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ALLIANCEBERNSTEIN L.P. holds $800,528,984 across 41 Drug Manufacturers - Specialty & Generic names. RDY ranks #4 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,633,318	$429,494,520
2	UTHR	UNITED THERAPEUTICS Corp	220,634	$130,831,549
3	NBIX	Neurocrine Biosciences Inc	523,533	$68,970,237
4	RDY	Dr Reddys Laboratories Ltd This page	2,541,889	$35,205,162
5	KNSA	Kiniksa Pharmaceuticals International, plc	598,888	$28,836,457
6	VTRS	Viatris Inc	1,229,714	$16,613,436
7	ELAN	Elanco Animal Health Inc	624,049	$14,933,492
8	HIMS	Hims & Hers Health, Inc.	501,138	$10,403,624

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,205,162	2,541,889	+8384.0%	Shares	Defined	2026-05-15
2025-12-31	$420,652	29,961	+87.8%	Shares	Defined	2026-02-17
2025-09-30	$222,981	15,950	+2.8%	Shares	Defined	2025-11-14
2025-06-30	$233,115	15,510	-21.3%	Shares	Defined	2025-08-14
2023-09-30	$263,494	19,702	+15.7%	Shares	Defined	2023-11-14
2023-06-30	$214,927	17,028	+30.9%	Shares	Defined	2023-08-15
2023-03-31	$148,131	13,010	+28.7%	Shares	Defined	2023-05-15
2020-09-30	$140,636	10,109	0.0%	Shares	Defined	2020-11-12
2020-06-30	$107,175	10,109	-4.2%	Shares	Defined	2020-08-13
2020-03-31	$85,096	10,550	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.